Comparative analysis of three- and two-antibody cocktails to AMACR and basal cell markers for the immunohistochemical diagnosis of prostate carcinoma

Diagnostic Pathology

Volumn 7, Issue 1, 2012, Pages

  Dabir, Parag D ^a   Ottosen, Peter ^a   Høyer, Søren ^a   Hamilton Dutoit, Stephen ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

AMACR; Antibody cocktail; Basal cells; Cytokeratins; Immunohistochemistry; p63; Prostate carcinoma

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ALPHA-METHYLACYL-COA RACEMASE; CKAP4 PROTEIN, HUMAN; CYTOKERATIN 5; DIAGNOSTIC AGENT; ISOMERASE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; COMPARATIVE STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; PROSTATE TUMOR; SENSITIVITY AND SPECIFICITY;

ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; MALE; MEMBRANE PROTEINS; PROSTATIC NEOPLASMS; RACEMASES AND EPIMERASES; SENSITIVITY AND SPECIFICITY;

EID: 84865752898     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-7-81     Document Type: Article

References (13)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61(2):69-90. 10.3322/caac.20107, 21296855.
2. Molinie V, Fromont G, Sibony M, Vieillefond A, Vassiliu V, Cochand-Priollet B, et al. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol 2004, 17(10):1180-1190. 10.1038/modpathol.3800197, 15205683.
3. Ng VW, Koh M, Tan SY, Tan PH. Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Am J Clin Pathol 2007, 127(2):248-253. 10.1309/JCFW75KGFWQUHVQD, 17210521.
4. Kumaresan K, Kakkar N, Verma A, Mandal AK, Singh SK, Joshi K. Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer. Diagn Pathol 2010, 22(5):83.
5. Trpkov K, Bartczak-McKay J, Yilmaz A. Usefulness of cytokeratin 5/6 and AMACR applied as double sequential immunostains for diagnostic assessment of problematic prostate specimens. Am J Clin Pathol 2009, 132(2):211-220. 10.1309/AJCPGFJP83IXZEUR, 19605815.
6. Scarpelli M, Mazzucchelli R, Barbisan F, Santinelli A, Lopez-Beltran A, Cheng L, Montironi R. Is there a role for prostate tumour overexpressed-1 in the diagnosis of HGPIN and of prostatic adenocarcinoma? A comparison with alpha-methylacyl CoA racemase. Int J Immunopathol Pharmacol 2012, 25(1):67-74.
7. Humphrey PA. Diagnosis of adenocarcinoma in prostate needle biopsy tissue. J Clin Pathol 2007, 60(1):35-42. 10.1136/jcp.2005.036442, 1860598, 17213347.
8. Montironi R, Scarpelli M, Mazzucchelli R, Cheng L, Lopez-Beltran A. The spectrum of morphology in non-neoplastic prostate including cancer mimics. Histopathology 2012, 60(1):41-58. 10.1111/j.1365-2559.2011.04000.x, 22212077.
9. Jiang Z, Li C, Fischer A, Dresser K, Woda BA. Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens. Am J Clin Pathol 2005, 123(2):231-236. 10.1309/1G1NK9DBGFNB792L, 15842047.
10. Iczkowski KA. Current prostate biopsy interpretation - Criteria for cancer, atypical small acinar proliferation, high-grade prostatic intraepithelial neoplasia, and use of immunostains. Arch Pathol Lab Med 2006, 130(6):835-843.
11. Molinie V, Herve JM, Lugagne PM, Lebret T, Botto H. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy. BJU Int 2006, 97(5):1109-1115. 10.1111/j.1464-410X.2006.06069.x, 16643500.
12. Evans AJ. Alpha-methylacyl CoA racemase (P504S): overview and potential uses in diagnostic pathology as applied to prostate needle biopsies. J Clin Pathol 2003, 56(12):892-897. 10.1136/jcp.56.12.892, 1770134, 14645345.
13. Nordic Immunohistochemical Quality Control- Cytokeratins http://www.nordiqc.org/Epitopes/Cytokeratins/Cytokeratins.htm.